Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-16-001415
Filing Date
2016-09-19
Accepted
2016-09-19 16:23:52
Documents
1
Period of Report
2016-09-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_4237.html 4  
1 PRIMARY DOCUMENT doc4_4237.xml 4 5513
  Complete submission text file 0001638599-16-001415.txt   7021
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORONADO BIOSCIENCES, INC. 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Avgerinos George (Reporting) CIK: 0001578699 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 161892005